<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01594047</url>
  </required_header>
  <id_info>
    <org_study_id>metadone</org_study_id>
    <nct_id>NCT01594047</nct_id>
  </id_info>
  <brief_title>Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone</brief_title>
  <official_title>Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: In perioperative period inhibition of N-Methyl-D-Aspartate receptor prevents
      opioid-induced hyperalgesia and reduce postoperative opioid requirement after abdominal
      surgery. Methadone is both a µ-opioid receptor agonist like Morphine and a
      N-Methyl-D-Aspartate antagonist. Study Aim. To evaluate the efficacy of intraoperative
      Ketamine and postoperative Methadone analgesia in preventing opioid-induced hyperalgesia
      after abdominal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      not desired
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the extent of hyperalgesia area proximal to surgical wound</measure>
    <time_frame>24 and 48 hours after surgery</time_frame>
    <description>Hyperalgesia is determined by stimulating with a won Fray hair N°16 along three line at right angle to the top, middle and bottom sides of the surgical incision. Each line start from the edge of abdomen to the surgical incision.
Stimulation continue from edge toward the surgical incision untill the patients reported a worsening in sensation The distance from the incision to where sensation change was measured and the three assessments was calculated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain intensity</measure>
    <time_frame>24 and 40 hours after surgery</time_frame>
    <description>A Numerical rating scale is used to quantifie pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>opioids related adverse events</measure>
    <time_frame>24 and 48 hours after surgery</time_frame>
    <description>post operative nause and vomiting, respiratory depression.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Post Operative Pain</condition>
  <condition>Hyperalgesia</condition>
  <arm_group>
    <arm_group_label>zero/morphine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient received a standard balance anaesthesia and morphine for post operative pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ketamine/morphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients received a balance anaesthesia supplemented by low dose of ketamine and Morphine by PCA device for postoperative pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>zero/metadone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients received a standard balance anaesthesia and methadone by PCA device for postoperative pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ketamine/methadone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received a balance anaesthesia supplemented with low dose of ketamine and Methadone by PCA device for postoperative pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine infusion</intervention_name>
    <description>Ketamine infusion scheme: 5mcg/Kg/min from induction od anaesthesia for 10 min, than 2,5mcg/Kg/min for 20 min and than 2 mcg/Kg/min to the end of surgery</description>
    <arm_group_label>ketamine/morphine</arm_group_label>
    <arm_group_label>ketamine/methadone</arm_group_label>
    <other_name>hyperalgesia-blocker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone PCA</intervention_name>
    <description>Methadone administered by a PCA system (dose 2 mg, lock-out 12min.)</description>
    <arm_group_label>zero/metadone</arm_group_label>
    <arm_group_label>ketamine/methadone</arm_group_label>
    <other_name>hyperalgesia-blocker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing open colo-rectal surgery

        Exclusion Criteria:

          -  ASA status more than II, history of chronic pain, ischemic heart disease or chronic
             pulmonary disease, allergy to any drugs used in the protocol. Body Max Index more than
             35.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emiliano Tognoli</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione IRCCS Istituto Nazionale dei Tumori</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emiliano Tognoli</last_name>
    <phone>02/23902176</phone>
    <email>Emiliano.Tognoli@istitutotumori.mi.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Langer Martin</last_name>
    <phone>02/23902282</phone>
    <email>Martin.Langer@istitutotumori.mi.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondazione IRCCS Istituto Nazionale dei Tumori</name>
      <address>
        <city>Milano</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Emiliano Tognoli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2012</study_first_posted>
  <last_update_submitted>May 15, 2012</last_update_submitted>
  <last_update_submitted_qc>May 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</investigator_affiliation>
    <investigator_full_name>Emiliano Tognoli</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <keyword>hyperalgesia</keyword>
  <keyword>Patient controlled analgesia</keyword>
  <keyword>morphine</keyword>
  <keyword>methadone</keyword>
  <keyword>ketamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Methadone</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 27, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

